Harness Therapeutics

United Kingdom
Cambridge, England, United Kingdom, CB22 3AT

Company profile

Harness Therapeutics company profile

Harness Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currently hard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. We have a particular focus on CNS and opthalmologic disorders but our platform has applications in multiple therapy areas

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
CB22 3AT
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
5
Total equity funding
$23.8M
Last funding
Series Unknown / 2025-01-27
Last equity funding
Series Unknown
Investors
5
Lead investors
5
Founders
2
Articles
35

Founders and investors

Founders

Piero CarninciStefano Gustincich

Lead investors

Dementia Discovery FundEpidarex CapitalOno Venture InvestmentSV Health InvestorsTakeda Ventures

Investors

Dementia Discovery FundEpidarex CapitalOno Venture InvestmentSV Health InvestorsTakeda Ventures